Snowflake Crushes Q2 Earnings: Why I'm Still Not Buying

Snowflake (SNOW) reported strong Q2 results, including 32% product revenue growth, 125% net revenue retention, and an 11% non-GAAP EBIT margin, while strategically expanding its total addressable market to $355 billion through AI initiatives and raising FY2026 revenue guidance to $4.395 billion. Despite this robust operational performance and growth outlook, the stock faces scrutiny over its premium valuation and projected future EBIT margin declines, leading one analyst to issue a 'hold' rating, citing overvaluation and suggesting a 20-30% price correction is needed for a compelling investment opportunity.

Analysis

Snowflake (SNOW) demonstrated robust operational strength in its Q2 results, highlighted by a 32% increase in product revenue, a strong 125% net revenue retention rate, and an 11% non-GAAP EBIT margin. The company is actively expanding its total addressable market (TAM) from $170 billion to a projected $355 billion by capitalizing on AI adoption through its Cortex AI and Snowpark platforms, supplemented by the Crunchy Data acquisition. Management has raised its FY2026 revenue guidance to $4.395 billion, implying a 27% year-over-year growth rate. However, this positive operational picture is tempered by significant valuation concerns and forward-looking headwinds. The stock trades at premium multiples, and while consensus projects a 41% EPS CAGR over five years, the sustainability of this growth is questioned. Furthermore, guidance indicates that EBIT margins are expected to decline in subsequent quarters from the 11% achieved in Q2, creating a conflict between strong current execution and a challenging valuation framework that, according to the analyst, requires a 20-30% price correction to present a compelling investment opportunity.

Key Decisions for Investors

• Given the 'hold' rating and strong fundamentals, current investors might maintain their positions but should be cognizant of the significant overvaluation risk highlighted in the analysis.
• Prospective investors should exercise caution and consider waiting for a potential price correction of 20-30%, as suggested, before initiating a position, despite the company's impressive growth metrics.
• Monitor upcoming quarterly reports closely for any deceleration in product revenue growth from the 32% trend and for confirmation of the projected decline in EBIT margins, as these will be critical tests for the stock's premium valuation.